Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - hydrocortisone, quantity: 20 mg - tablet, uncoated - excipient ingredients: povidone; magnesium stearate; macrogol 8000; lactose monohydrate; maize starch - indications as at 6 may 1992: hydrocortisone is indicated for replacement therapy in addison's disease or chronic adrenocortical insufficiency secondary to hypopituitarism.

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - hydrocortisone, quantity: 4 mg - tablet, uncoated - excipient ingredients: maize starch; magnesium stearate; lactose monohydrate; povidone - indications as at 6 may 1992: hydrocortisone is indicated for replacement therapy in addison's disease or chronic adrenocortical insufficiency secondary to hypopituitarism.

United States - English - NLM (National Library of Medicine)

carilion materials management - hydrocortisone (unii: wi4x0x7bpj) (hydrocortisone - unii:wi4x0x7bpj) - hydrocortisone 20 mg - hydrocortisone tablets are indicated in the following conditions. primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance) congenital adrenal hyperplasia non suppurative thyroiditis hypercalcemia associated with cancer as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: psoriatic arthritis rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy) ankylosing spondylitis acute and subacute bursitis acute nonspecific tenosynovitis acute gouty arthritis post-traumatic osteoarthritis synovitis of osteoarthritis epicondylitis during an exacerbation or as maintenance therapy in selected cases of: systemic lupus erythematosus systemic dermatomyositis (polymyositis) acute rheumatic carditis pem

United States - English - NLM (National Library of Medicine)

padagis israel pharmaceuticals ltd - hydrocortisone acetate (unii: 3x7931po74) (hydrocortisone - unii:wi4x0x7bpj), pramoxine hydrochloride (unii: 88ayb867l5) (pramoxine - unii:068x84e056) - hydrocortisone acetate 2.5 g in 100 g - topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

United States - English - NLM (National Library of Medicine)

actavis pharma, inc. - hydrocortisone (unii: wi4x0x7bpj) (hydrocortisone - unii:wi4x0x7bpj) - hydrocortisone 25 mg in 1 g - topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.

United States - English - NLM (National Library of Medicine)

galentic pharma (india) private limited - hydrocortisone acetate (unii: 3x7931po74) (hydrocortisone - unii:wi4x0x7bpj) - hydrocortisone acetate 1 g in 100 g - hydrocortisone is for temporary relief of; - minor skin irritations itching and rashes due to; - eczema - insect bites - poison ivy - poison oak - poison sumac - soaps - detergents - cosmetics - jewelry and for external itching of; -  genital - feminine and - anal itching - in the eyes - longer than 1 week unless directed by a physician - for diaper rash - if you have vaginal discharge - more than the recommended daily dosage unless directed by a doctor - in the rectum bu using fingers or any other mechanical device or applicator - for temporary relief of minor skin irritations and external itching. - the condition persists or gets worse - symptoms clear up and occur again within a few days - you are pregnant or breast feeding

United States - English - NLM (National Library of Medicine)

kinray inc. - hydrocortisone acetate (unii: 3x7931po74) (hydrocortisone - unii:wi4x0x7bpj) - hydrocortisone acetate 1 g in 100 g - hydrocortisone is for temporary relief of; minor skin irritations itching and rashes due to; eczema insect bites poison ivy poison oak poison sumac soaps detergents cosmetics jewelry and for external itching of; genital feminine and anal itching - in the eyes - longer than 1 week unless directed by a physician - for diaper rash - if you have vaginal discharge - more than the recommended daily dosage unless directed by a doctor - in the rectum bu using fingers or any other mechanical device or applicator - for temporary relief of minor skin irritations and external itching. - the condition persists or gets worse - symptoms clear up and occur again within a few days - you are pregnant or breast feeding

United States - English - NLM (National Library of Medicine)

kinray inc. - hydrocortisone acetate (unii: 3x7931po74) (hydrocortisone - unii:wi4x0x7bpj) - hydrocortisone acetate 1 g in 100 g - hydrocortisone is for temporary relief of; minor skin irritations itching and rashes due to; eczema insect bites poison ivy poison oak poison sumac soaps detergents cosmetics jewelry and for external itching of; genital feminine and anal itching - in the eyes - longer than 1 week unless directed by a physician - for diaper rash - if you have vaginal discharge - more than the recommended daily dosage unless directed by a doctor - in the rectum bu using fingers or any other mechanical device or applicator - for temporary relief of minor skin irritations and external itching. - the condition persists or gets worse - symptoms clear up and occur again within a few days - you are pregnant or breast feeding

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - hydrocortisone (unii: wi4x0x7bpj) (hydrocortisone - unii:wi4x0x7bpj) - hydrocortisone 10 mg - hydrocortisone tablets are indicated in the following conditions. primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance) congenital adrenal hyperplasia non suppurative thyroiditis hypercalcemia associated with cancer as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in: psoriatic arthritis rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy) ankylosing spondylitis acute and subacute bursitis acute nonspecific tenosynovitis acute gouty arthritis post-traumatic osteoarthritis synovitis of osteoarthritis epicondylitis during an exacerbation or as maintenance therapy in selected cases of: systemic lupus erythematosus systemic dermatomyositis (polymyositis) acute rheumatic

United States - English - NLM (National Library of Medicine)

e. fougera & co. a division of fougera pharmaceuticals inc. - hydrocortisone (unii: wi4x0x7bpj) (hydrocortisone - unii:wi4x0x7bpj) - hydrocortisone 25 mg in 1 g - topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.